Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441
DNA double-strand breaks (DSB) are the most cytotoxic lesions induced by ionizing radiation and topoisomerase II poisons, such as etoposide and doxorubicin. A major pathway for the repair of DSB is nonhomologous end joining, which requires DNA-dependent protein kinase (DNA-PK) activity. We investigated the therapeutic use of a potent, specific DNA-PK inhibitor (NU7441) in models of human cancer. We measured chemosensitization by NU7441 of topoisomerase II poisons and radiosensitization in cells deficient and proficient in DNA-PK(CS) (V3 and V3-YAC) and p53 wild type (LoVo) and p53 mutant (SW620) human colon cancer cell lines by clonogenic survival assay. Effects of NU7441 on DSB repair and cell cycle arrest were measured by gammaH2AX foci and flow cytometry. Tissue distribution of NU7441 and potentiation of etoposide activity were determined in mice bearing SW620 tumors. NU7441 increased the cytotoxicity of ionizing radiation and etoposide in SW620, LoVo, and V3-YAC cells but not in V3 cells, confirming that potentiation was due to DNA-PK inhibition. NU7441 substantially retarded the repair of ionizing radiation-induced and etoposide-induced DSB. NU7441 appreciably increased G(2)-M accumulation induced by ionizing radiation, etoposide, and doxorubicin in both SW620 and LoVo cells. In mice bearing SW620 xenografts, NU7441 concentrations in the tumor necessary for chemopotentiation in vitro were maintained for at least 4 hours at nontoxic doses. NU7441 increased etoposide-induced tumor growth delay 2-fold without exacerbating etoposide toxicity to unacceptable levels. In conclusion, NU7441 shows sufficient proof of principle through in vitro and in vivo chemosensitization and radiosensitization to justify further development of DNA-PK inhibitors for clinical use.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2006 |
---|---|
Erschienen: |
2006 |
Enthalten in: |
Zur Gesamtaufnahme - volume:66 |
---|---|
Enthalten in: |
Cancer research - 66(2006), 10 vom: 15. Mai, Seite 5354-62 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhao, Yan [VerfasserIn] |
---|
Anmerkungen: |
Date Completed 18.07.2006 Date Revised 21.03.2022 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM162883056 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM162883056 | ||
003 | DE-627 | ||
005 | 20231223095149.0 | ||
007 | tu | ||
008 | 231223s2006 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0543.xml |
035 | |a (DE-627)NLM162883056 | ||
035 | |a (NLM)16707462 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhao, Yan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441 |
264 | 1 | |c 2006 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 18.07.2006 | ||
500 | |a Date Revised 21.03.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a DNA double-strand breaks (DSB) are the most cytotoxic lesions induced by ionizing radiation and topoisomerase II poisons, such as etoposide and doxorubicin. A major pathway for the repair of DSB is nonhomologous end joining, which requires DNA-dependent protein kinase (DNA-PK) activity. We investigated the therapeutic use of a potent, specific DNA-PK inhibitor (NU7441) in models of human cancer. We measured chemosensitization by NU7441 of topoisomerase II poisons and radiosensitization in cells deficient and proficient in DNA-PK(CS) (V3 and V3-YAC) and p53 wild type (LoVo) and p53 mutant (SW620) human colon cancer cell lines by clonogenic survival assay. Effects of NU7441 on DSB repair and cell cycle arrest were measured by gammaH2AX foci and flow cytometry. Tissue distribution of NU7441 and potentiation of etoposide activity were determined in mice bearing SW620 tumors. NU7441 increased the cytotoxicity of ionizing radiation and etoposide in SW620, LoVo, and V3-YAC cells but not in V3 cells, confirming that potentiation was due to DNA-PK inhibition. NU7441 substantially retarded the repair of ionizing radiation-induced and etoposide-induced DSB. NU7441 appreciably increased G(2)-M accumulation induced by ionizing radiation, etoposide, and doxorubicin in both SW620 and LoVo cells. In mice bearing SW620 xenografts, NU7441 concentrations in the tumor necessary for chemopotentiation in vitro were maintained for at least 4 hours at nontoxic doses. NU7441 increased etoposide-induced tumor growth delay 2-fold without exacerbating etoposide toxicity to unacceptable levels. In conclusion, NU7441 shows sufficient proof of principle through in vitro and in vivo chemosensitization and radiosensitization to justify further development of DNA-PK inhibitors for clinical use | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one |2 NLM | |
650 | 7 | |a Chromones |2 NLM | |
650 | 7 | |a Histones |2 NLM | |
650 | 7 | |a Morpholines |2 NLM | |
650 | 7 | |a Protein Kinase Inhibitors |2 NLM | |
650 | 7 | |a Radiation-Sensitizing Agents |2 NLM | |
650 | 7 | |a gamma-H2AX protein, mouse |2 NLM | |
650 | 7 | |a Etoposide |2 NLM | |
650 | 7 | |a 6PLQ3CP4P3 |2 NLM | |
650 | 7 | |a DNA-Activated Protein Kinase |2 NLM | |
650 | 7 | |a EC 2.7.11.1 |2 NLM | |
700 | 1 | |a Thomas, Huw D |e verfasserin |4 aut | |
700 | 1 | |a Batey, Michael A |e verfasserin |4 aut | |
700 | 1 | |a Cowell, Ian G |e verfasserin |4 aut | |
700 | 1 | |a Richardson, Caroline J |e verfasserin |4 aut | |
700 | 1 | |a Griffin, Roger J |e verfasserin |4 aut | |
700 | 1 | |a Calvert, A Hilary |e verfasserin |4 aut | |
700 | 1 | |a Newell, David R |e verfasserin |4 aut | |
700 | 1 | |a Smith, Graeme C M |e verfasserin |4 aut | |
700 | 1 | |a Curtin, Nicola J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancer research |d 1945 |g 66(2006), 10 vom: 15. Mai, Seite 5354-62 |w (DE-627)NLM000001740 |x 1538-7445 |7 nnns |
773 | 1 | 8 | |g volume:66 |g year:2006 |g number:10 |g day:15 |g month:05 |g pages:5354-62 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 66 |j 2006 |e 10 |b 15 |c 05 |h 5354-62 |